US HPLC Market to Reach $2,763.9 Million by 2035, Driven by Growth in Biologics and Complex Therapeutics

US HPLC market was valued at $1,848.4 million in 2025 and is expected to reach $2,763.9 million by 2035, registering a CAGR of 4.2% over the forecast period from 2026 to 2035. The rapid expansion of biologics and complex therapeutic development in the US is a key driver of HPLC demand, particularly for advanced analytical characterization and quality control applications. In 2024, the US Food and Drug Administration approved 50 new therapies, including small molecules and biologics, marking one of the highest annual totals of novel drug approvals on record. This indicates that biologics represent a growing share of these approvals, with recent years averaging double-digit biologic approvals annually, particularly monoclonal antibodies and protein therapeutics.

Browse the full report description of “US High-Performance Liquid Chromatography (HPLC) Market Size, Share & Trends Analysis Report by Product Type (Consumables, Instruments, and Accessories), Application (Diagnostics, Clinical Research, Forensics, and Others), and Forecast 2026-2035” at https://www.omrglobal.com/industry-reports/us-hplc-market

The Center for Drug Evaluation and Research’s approval patterns reflect an increasing focus on complex molecular classes that require advanced separation science, such as peptide and protein drugs, which HPLC systems routinely analyze for impurity profiles, degradation products, and glycan compositions. This regulatory trend boosts long-term adoption and recurring usage of HPLC instruments, columns, and detectors across pharmaceutical development and quality assurance laboratories.

Innovation Leaders Transforming the High-Performance Liquid Chromatography (HPLC) Market

The key players in the HPLC market are Agilent Technologies, Inc., Thermo Fisher, Scientific Inc., Waters Corp., Shimadzu Corp., Danaher Corp.  (SCIEX), among others. These companies are driving innovation in the HPLC market through the development of high-resolution and ultra-high-pressure systems, improved column chemistries, and advanced detector technologies. Enhanced automation, software integration, and data accuracy are supporting evolving requirements for analytical precision, regulatory compliance, and workflow efficiency across pharmaceutical, biotechnology, food safety, and environmental testing markets globally.

• In April 2025, Waters Corporation announced the expansion of its MaxPeak Premier Reversed-Phase Column portfolio with MaxPeak Premier OBD Preparative Columns. The new columns were introduced at the 29th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products (WCBP 2025) in Washington, DC.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Application
• Competitive Landscape - Agilent Technologies, Inc., Thermo Fisher, Scientific Inc., Waters Corp., Shimadzu Corp., Danaher Corp. (SCIEX), among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

US High-Performance Liquid Chromatography (HPLC) Market Report Segment

By Product Type

• Consumables
• Instruments
• Accessories

By Application

• Diagnostics
• Clinical Research
• Forensics
• Others

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-hplc-market